Canadian marijuana producer Aurora Cannabis Inc. agreed to acquire CanniMed Therapeutics Inc. in a C$1.23 billion ($1 billion) cash-and-stock deal that would be the largest yet in the country’s red-hot cannabis industry.
Investors will get 3.4 Aurora shares for each CanniMed share, or they can accept cash limited in aggregate to C$140 million, the companies said Wednesday in a joint statement after Bloomberg News first reported the agreement. The deal values CanniMed at about C$50.29 a share, based on Tuesday’s closing price for Aurora of C$14.79. CanniMed closed at C$37.51.
In connection with the merger, CanniMed agreed to terminate a previously agreed takeover of Newstrike Resources Ltd. and will pay the company a C$9.5 million break fee.
Top image courtesy of Adobe Stock
Latest from Cannabis Business Times
- Navigating Cultivation Room Design: Optimization vs. Maximization
- Verano Opens 18th Medical Cannabis Dispensary in Pennsylvania
- Hundreds Interested in Kentucky’s Medical Cannabis Licenses; Just 17 Apply So Far
- Aurora Receives Expanded Cultivation, Unique Research Licenses for German Facility
- Curaleaf Opening 2 New York Medical Dispensaries, Launching Adult-Use Sales at 2 Other Stores
- Ohio’s Adult-Use Licensing Process Leads CBT’s Top Stories in July
- Planet 13 Launches Lifestyles Brand Company; Signs 1st Sponsored Athlete in UFC Title Contender Chito Vera
- LeafLink Acquires Leading Cannabis Banking Platform Dama Financial
